학술논문
An immunological signature to predict outcome in patients with triple-negative breast cancer with residual disease after neoadjuvant chemotherapy
Document Type
Article
Author
Source
In ESMO Open August 2022 7(4)
Subject
Language
ISSN
2059-7029